STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] PAINREFORM LTD. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

PainReform Ltd. (PRFX) filed a Form 6-K noting it issued a press release on November 5, 2025 titled “PainReform’s DeepSolar, Developing ‘DeepSolar Predict’ within the NVIDIA Connect Program, Featured in The Market Link’s ‘Watchlist Interview’ and Announces Progress Toward Pilot Projects.” The press release is attached as Exhibit 99.1 and incorporated by reference.

The report is signed by Ehud Geller, Executive Chairman of the Board and Interim Chief Executive Officer.

Positive
  • None.
Negative
  • None.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
Report of Foreign Private Issuer
 
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
 
For the month of November 2025
 
Commission File Number: 001-39481
 
PainReform Ltd.
(Translation of registrant’s name into English)
 
65 Yigal Alon St., Tel Aviv 6744316
Israel
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒          Form 40-F ☐


 
On November 5, 2025, PainReform Ltd. issued a press release entitled “PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects”. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Exhibit Index

Exhibit No.
 
Description
 
 
 
99.1

Press Release dated November 5, 2025.



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: November 5, 2025
PAINREFORM LTD.
 
 
 
By:
/s/ Ehud Geller
 
 
Ehud Geller
Executive Chairman of the Board and Interim Chief Executive Officer
 

 

FAQ

What did PRFX report in its latest Form 6-K?

PainReform reported it issued a press release on November 5, 2025, which is attached as Exhibit 99.1 and incorporated by reference.

What is included as Exhibit 99.1 in PRFX’s 6-K?

Exhibit 99.1 is the press release dated November 5, 2025.

What is the title of PainReform’s press release mentioned in the 6-K?

“PainReform’s DeepSolar, Developing ‘DeepSolar Predict’ within the NVIDIA Connect Program, Featured in The Market Link’s ‘Watchlist Interview’ and Announces Progress Toward Pilot Projects.”

Who signed the PainReform Form 6-K?

Ehud Geller, Executive Chairman of the Board and Interim Chief Executive Officer.

Where is PainReform’s principal executive office located?

65 Yigal Alon St., Tel Aviv 6744316, Israel.

Is the press release part of the official record of the report?

Yes. It is attached as Exhibit 99.1 and incorporated by reference.
Painreform Ltd

NASDAQ:PRFX

PRFX Rankings

PRFX Latest News

PRFX Latest SEC Filings

PRFX Stock Data

2.11M
1.81M
9.62%
3.13%
6.8%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Tel Aviv